國立虎尾科技大學 |

Bioactive lipid mediators = current reviews and protocols /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Bioactive lipid mediators/ edited by Takehiko Yokomizo, Makoto Murakami.
其他題名:	current reviews and protocols /
其他作者:	Murakami, Makoto.
出版者:	Tokyo :Imprint: Springer, : 2015.,
面頁冊數:	ix, 426 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Human Physiology. -
電子資源:	http://dx.doi.org/10.1007/978-4-431-55669-5
ISBN:	9784431556695

Bioactive lipid mediators = current reviews and protocols /
Bioactive lipid mediatorscurrent reviews and protocols /[electronic resource] :edited by Takehiko Yokomizo, Makoto Murakami. - Tokyo :Imprint: Springer,2015. - ix, 426 p. :ill., digital ;24 cm.

This book summarizes the most recent progress in the studies of lipid mediators from the molecular to clinical level and introduces newly created tools for analysis including imaging mass spectrometry. Comprising 29 chapters divided into four major parts, the book describes the molecular natures of enzymes, transporters, and receptors for lipid mediators (Part I), the function of lipid mediators in Drosophila and Zebrafish (Part II), the relationships between lipid mediators and various diseases (Part III), and detailed procedures of extraction, preparation, and quantification of lipid mediators (Part IV) Research on lipid mediators initially started with analysis of the action of aspirin, and subsequent biochemical experiments identified many enzymes and receptors responsible for the biosynthesis and signal transduction of individual lipid mediators. Through the phenotypic analyses of transgenic and knockout mice, it has been shown that the dysregulation of some lipid mediators causes inflammatory, immune, or oncogenic disorders. Lipid mediators have attracted increased attention because their structures are conserved among different species, and their biosynthetic and signaling pathways have been deciphered at the molecular level. Many drugs that target lipid mediators are already being used in hospitals, and this book suggests further possibilities for development of a wide variety of such drugs. Very recently, highly sensitive mass spectrometry has begun to be used to identify novel lipid mediators that are present only in trace amounts in tissues but with robust biological activity. Written by international experts, this book provides readers a comprehensive view of lipid mediators and related topics and helps in the process of determining research targets for the near future.

ISBN: 9784431556695

Standard No.: 10.1007/978-4-431-55669-5doiSubjects--Topical Terms:

668349
Human Physiology.

LC Class. No.: QP751

Dewey Class. No.: 572.57

Bioactive lipid mediators = current reviews and protocols /
LDR:02760nam a2200301 a 4500 001 838072
003 DE-He213
005 20160414141319.0
006 m d
007 cr nn 008maaau
008 160616s2015 ja s 0 eng d
020 $a 9784431556695 $q (electronic bk.)
020 $a 9784431556688 $q (paper)
024 7 $a 10.1007/978-4-431-55669-5 $2 doi
035 $a 978-4-431-55669-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QP751
072 7 $a PSBH $2 bicssc
072 7 $a SCI007000 $2 bisacsh
082 0 4 $a 572.57 $2 23
090 $a QP751 $b .B615 2015
245 0 0 $a Bioactive lipid mediators $h [electronic resource] : $b current reviews and protocols / $c edited by Takehiko Yokomizo, Makoto Murakami.
260 $a Tokyo : $c 2015. $b Imprint: Springer, $b Springer Japan :
300 $a ix, 426 p. : $b ill., digital ; $c 24 cm.
520 $a This book summarizes the most recent progress in the studies of lipid mediators from the molecular to clinical level and introduces newly created tools for analysis including imaging mass spectrometry. Comprising 29 chapters divided into four major parts, the book describes the molecular natures of enzymes, transporters, and receptors for lipid mediators (Part I), the function of lipid mediators in Drosophila and Zebrafish (Part II), the relationships between lipid mediators and various diseases (Part III), and detailed procedures of extraction, preparation, and quantification of lipid mediators (Part IV) Research on lipid mediators initially started with analysis of the action of aspirin, and subsequent biochemical experiments identified many enzymes and receptors responsible for the biosynthesis and signal transduction of individual lipid mediators. Through the phenotypic analyses of transgenic and knockout mice, it has been shown that the dysregulation of some lipid mediators causes inflammatory, immune, or oncogenic disorders. Lipid mediators have attracted increased attention because their structures are conserved among different species, and their biosynthetic and signaling pathways have been deciphered at the molecular level. Many drugs that target lipid mediators are already being used in hospitals, and this book suggests further possibilities for development of a wide variety of such drugs. Very recently, highly sensitive mass spectrometry has begun to be used to identify novel lipid mediators that are present only in trace amounts in tissues but with robust biological activity. Written by international experts, this book provides readers a comprehensive view of lipid mediators and related topics and helps in the process of determining research targets for the near future.
650 2 4 $a Human Physiology. $3 668349
650 2 4 $a Cell Biology. $3 593889
650 2 4 $a Lipidology. $3 681911
650 1 4 $a Life Sciences. $3 593888
650 0 $a Pharmacology. $3 583819
650 0 $a Lipids $x Research. $3 1068990
650 0 $a Lipids $x Synthesis. $3 583994
700 1 $a Murakami, Makoto. $3 1068989
700 1 $a Yokomizo, Takehiko. $3 1068988
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55669-5
950 $a Biomedical and Life Sciences (Springer-11642)